Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Anderson, Karen E, Stamler, David, Davis, Mat D, Factor, Stewart A, Hauser, Robert A, Isojärvi, Jouko, Jarskog, L Fredrik, Jimenez-Shahed, Joohi, Kumar, Rajeev, McEvoy, Joseph P, Ochudlo, Stanislaw, OLanguage:
english
Journal:
The Lancet Psychiatry
DOI:
10.1016/S2215-0366(17)30236-5
Date:
June, 2017
File:
PDF, 464 KB
english, 2017